An Open-label study of GS-7977 + Ribavirin for 12 weeks in subjects with chronic HCV infection who participated in prior studies evaluating GS-7977 (GT2 & GT3)

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/1230/11/14